Press Releases - 2001



There are no webcasts or presentations available at this time.
Keyword Search
 
Receive E-mail AlertsE-mail Alerts
Category
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
DateTitle 
11/29/01Three Million Additional Doses of Flu Vaccine Now Available to U.S. Doctors From Henry Schein, Inc.; CDC Bulletin Recommends Continued Vaccination
MELVILLE, N.Y., Nov 29, 2001 (BUSINESS WIRE) -- Henry Schein, Inc. (Nasdaq:HSIC), the largest provider of healthcare supplies to office-based practitioners in the North American and European markets, announced today that it has obtained new inventory and will be making three million additional doses of flu vaccine immediately available for the remainder of the U.S. influenza season. The Company also said that it has a special customer service phone number to help doctors and other heal... 
Printer Friendly Version
11/06/01Henry Schein Reports Record Quarterly Results; Third Quarter EPS Increases 23% to $0.58, Net Sales Up 9.4%, Operating Cash Flow Reaches $50 Million
MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 6, 2001-- Company Updates 2001 EPS Guidance, Introduces 2002 EPS Guidance Henry Schein, Inc. (Nasdaq:HSIC), the largest provider of healthcare supplies to office-based practitioners in the combined North American and European markets, today announced financial results for the third quarter of 2001. For the three months ended September 30, 2001, the Company reported all-time record financial performance, including: ... 
Printer Friendly Version
11/05/01Henry Schein Acquires Zila's Full-Service Dental Distribution Operations; Further Strengthens Company's Position in Kentucky, California and Texas
MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 5, 2001--Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based practitioners in the combined North American and European markets, today announced that it has acquired the full-service dental distribution operations of Zila, Inc. (Nasdaq: ZILA). Terms of the all-cash acquisition were not disclosed. Through this purchase, which is expected to be $0.01-$0.02 accretive in 2002, and non-dilutive for ... 
Printer Friendly Version
10/31/01Henry Schein to Webcast Third Quarter Earnings Conference Call, November 6, 2001, 10 a.m. EST
MELVILLE, N.Y.--(BUSINESS WIRE)--Oct. 31, 2001--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will release its third quarter 2001 financial results before the stock market opens on November 6, 2001, and provide a live Webcast of its earnings conference call on the same day at 10 a.m. Eastern Standard Time. Speakers on the call will include: Stanley M. Bergman, Chairman, Chief Executive Officer and President; and Steven Paladino, Executive Vice President and Chief Financi... 
Printer Friendly Version
10/18/01Henry Schein Renews Exclusive Supplier Agreement With the American Medical Association for Purchasing Program
MELVILLE, N.Y., Oct 18, 2001 (BUSINESS WIRE) -- Henry Schein Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office- based practitioners in the North American and European markets, signed a new agreement with the American Medical Association (AMA) continuing its role as the AMA's preferred supplier of medical, surgical and laboratory supplies, equipment, pharmaceuticals and vaccines. Under the three-year contract, AMA members have access to a formulary purchasing pr... 
Printer Friendly Version
10/05/01Henry Schein Releases `Dental Career Planner' CD-ROM To Help New Practitioners Evaluate Their Dental Practice Options
MELVILLE, N.Y., Oct 5, 2001 (BUSINESS WIRE) -- New planning tool also valuable to practicing dentists in evaluating their future Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based practitioners in the North American and European markets, announced today the release of an interactive CD-ROM designed to help new dental practitioners make informed decisions about their career options. The new software program, titled Dental Career Planner: A ... 
Printer Friendly Version
10/01/01Dentrix Introduces DXONE At University of Pennsylvania School of Dental Medicine
MELVILLE, N.Y.--(BUSINESS WIRE)--Oct. 1, 2001-- DXONE Enterprise System Delivers Superior Practice Management, Enhances Patient Treatment Dentrix Dental Systems, Inc. has introduced DXONE, its enterprise practice management software, at the University of Pennsylvania School of Dental Medicine (SDM). Dentrix Dental Systems is a division of Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based pra... 
Printer Friendly Version
09/25/01Schein Family Members Sell 2.5 Million Shares of Henry Schein Common Stock
MELVILLE, N.Y., Sep 25, 2001 (BUSINESS WIRE) -- Company withdraws registration statement Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based practitioners in the combined North American and European markets, today reported that Marvin Schein sold approximately 2.0 million shares of Henry Schein, Inc. common stock and other Schein family members sold approximately 500,000 shares of Company common stock (2.5 million aggregate) following the clos... 
Printer Friendly Version
08/07/01Henry Schein Reports Second Quarter Results; EPS Increases 17% to $0.48, Operating Cash Flow Exceeds $41 Million; Company Reaffirms 2001 EPS Guidance
MELVILLE, N.Y., Aug 7, 2001 (BUSINESS WIRE) -- Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based practitioners in the combined North American and European markets, today announced financial results for the second quarter of 2001. For the three months ended June 30, 2001, net sales increased 6.6% to $606.3 million, from $568.6 million in the second quarter of last year. In local currencies, net sales increased 8%. Net income for the second quar... 
Printer Friendly Version
07/31/01Henry Schein to Webcast Second Quarter Earnings Conference Call, August 7, 2001, 10 a.m. EDT
MELVILLE, N.Y., Jul 31, 2001 (BUSINESS WIRE) -- Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will release its second quarter 2001 financial results before the stock market opens on August 7, 2001, and provide a live webcast of its earnings conference call on the same day at 10 a.m. EDT. Speakers on the call will include: Stanley M. Bergman, Chairman, Chief Executive Officer and President; and Steven Paladino, Executive Vice President and Chief Financial Officer. Investors m... 
Printer Friendly Version
06/12/01Henry Schein Announces Proposed Stock Offering by Certain Schein Family Members
MELVILLE, N.Y., Jun 12, 2001 (BUSINESS WIRE) -- Henry Schein, Inc. (NASDAQ: HSIC) today announced that it intends to file a registration statement with the Securities Exchange Commission for the underwritten offer and sale of approximately 4,000,000 currently outstanding shares of its common stock held by certain members of the Schein family. The selling stockholders have not been officers of the Company since prior to the Company's initial public offering in 1995. The Company anticipat... 
Printer Friendly Version
05/02/01Henry Schein to Webcast First Quarter Earnings Conference Call, May 8, 2001, 11 a.m. EDT
MELVILLE, N.Y.--(BUSINESS WIRE)--May 2, 2001--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will release its first quarter 2001 financial results before the stock market opens on May 8, 2001, and provide a live webcast of its earnings conference call on the same day at 11 a.m. EDT. Speakers on the call will include: Stanley M. Bergman, Chairman, Chief Executive Officer and President; and Steven Paladino, Executive Vice President and Chief Financial Officer. Inves... 
Printer Friendly Version
03/06/01Henry Schein Reports 43% Growth in Fourth Quarter Earnings
MELVILLE, N.Y.--(BUSINESS WIRE)--March 6, 2001-- EPS Increases 37% to $0.52, Cash Flow From Operations Improves to $68 Million; Company Provides 2001 EPS Guidance Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based practitioners in the combined North American and European markets, today announced financial results for the fourth quarter and full-year 2000. For the ... 
Printer Friendly Version
02/28/01Henry Schein to Webcast Fourth Quarter and Full-Year Earnings Conference Call, March 6, 2001, 10 A.M. EST
MELVILLE, N.Y.--(BUSINESS WIRE)--Feb. 28, 2001--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will release its fourth quarter and full-year 2000 financial results before the stock market opens on March 6, 2001, and provide a live Webcast of its earnings conference call on the same day at 10 a.m. EST. Speakers on the call will include: Stanley M. Bergman, Chairman, Chief Executive Officer and President; and Steven Paladino, Executive Vice President and Chief Financial Of... 
Printer Friendly Version
02/05/01Henry Schein to Participate in UBS Warburg Global Healthcare Services Conference
MELVILLE, N.Y.--(BUSINESS WIRE)--Feb. 5, 2001--Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based practitioners in North America and Europe, will be participating in the UBS Warburg Global Healthcare Services Conference being held this week in New York City. The conference features presentations and panel discussions by executives from more than 170 leading healthcare companies. Stanley M. Bergman, Henry Schein's Chief Executive ... 
Printer Friendly Version
01/29/01New Henry Schein Web Site Makes Online Ordering Easier
MELVILLE, N.Y.--(BUSINESS WIRE)--Jan. 29, 2001-- Instant Customer Registration, Advanced Product Search, Streamlined Purchasing Options and Valuable Supply Procurement Tools Among Features Building on its industry-leading success in electronic and Web-based marketing to healthcare professionals, Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare supplies to office-based practitioners in North America and ... 
Printer Friendly Version
01/23/01Clal Biotechnology Industries Completes Investment in OralScan Laboratories
TEL AVIV, Israel & SUFFERN, N.Y.--(BUSINESS WIRE)--Jan. 23, 2001-- Clal Biotechnology Industries Ltd. ("CBI"), Israel's leading investor in the life sciences, has recently completed an additional investment overseas. Following its investment in September in Immuno-Designed Molecules S.A. of France, CBI has recently completed an investment in OralScan(R) Laboratories, Inc. ("OralScan"), a Suffern, NY,-based company which specializes in early cancer detection. CBI has acte... 
Printer Friendly Version